Latest & greatest articles for tuberculosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on tuberculosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on tuberculosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for tuberculosis

161. Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis.

Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis. Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item (...) : 26649984 Format MeSH and Other Data E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Dec 17;373(25):e29. doi: 10.1056/NEJMx150041. Epub 2015 Dec 9. Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis. [No authors listed] Erratum for [N Engl J Med. 2015] PMID: 26649984 DOI: Free full text Publication type Full Text Sources PubMed

NEJM2015 Full Text: Link to full Text with Trip Pro

162. Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora

Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora 26820895 2016 01 29 2018 11 13 2193-9616 3 1 2015 Dec In silico pharmacology In Silico Pharmacol Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora. 10 10.1186/s40203-015-0014-1 There is an urgent need to discover (...) and develop new drugs to combat Mycobacterium tuberculosis, the causative agent of tuberculosis (TB) in humans. In recent years, there has been a renewed interest in the discovery of new anti-TB agents from natural sources. In the present investigation, molecular docking studies were carried out on two ellagic acid derivatives, namely pteleoellagic acid (1) isolated from Ludwigia adscendens, and 3,3'-di-O-methyl ellagic acid 4-O-α-rhamnopyranoside (2) isolated from Trewia nudiflora, to investigate

In silico pharmacology2015 Full Text: Link to full Text with Trip Pro

163. Disseminated Tuberculosis in an Immunocompetent Patient: The Answer is in the Liver

Disseminated Tuberculosis in an Immunocompetent Patient: The Answer is in the Liver 28868461 2018 11 13 2341-4545 23 4 2016 Jul-Aug GE Portuguese journal of gastroenterology GE Port J Gastroenterol Disseminated Tuberculosis in an Immunocompetent Patient: The Answer is in the Liver. 208-213 10.1016/j.jpge.2015.10.002 Tuberculosis, a chronic infectious disease caused by Mycobacterium tuberculosis , may invade all organs but mainly affect the lungs. We report a case of disseminated tuberculosis (...) suggested the diagnosis of constrictive pericarditis. Liver biopsy revealed granulomatous lesions with central caseating necrosis. Tuberculosis is usually associated with atypical clinical manifestations. Imaging examination combined with histopathological features, a high index of clinical suspicion and improvement with antibacilar therapeutic are necessary to confirm a diagnosis, especially in the cases of extrapulmonary tuberculosis. Ribeiro Suzane S Gastroenterology Department, Hospital São Bernardo

GE Portuguese journal of gastroenterology2015 Full Text: Link to full Text with Trip Pro

164. Treatment of Tuberculosis.

Treatment of Tuberculosis. Treatment of Tuberculosis. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26605929 Format MeSH and Other Data E-mail Subject Additional text E-mail Add to Clipboard Add (...) to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Nov 26;373(22):2149-60. doi: 10.1056/NEJMra1413919. Treatment of Tuberculosis. , , . PMID: 26605929 DOI: [Indexed for MEDLINE] Publication type MeSH terms Substance Full Text Sources Medical PubMed Commons 0 comments How to cite this comment: Supplemental Content Full text links You are here: > > PubMed Simple NCBI Directory Getting Started Resources Popular Featured NCBI

NEJM2015

165. Data for action: collection and use of local data to end tuberculosis.

Data for action: collection and use of local data to end tuberculosis. Accelerating progress in the fight against tuberculosis will require a drastic shift from a strategy focused on control to one focused on elimination. Successful disease elimination campaigns are characterised by locally tailored responses that are informed by appropriate data. To develop such a response to tuberculosis, we suggest a three-step process that includes improved collection and use of existing programmatic data (...) , collection of additional data (eg, geographic information, drug resistance, and risk factors) to inform tailored responses, and targeted collection of novel data (eg, sequencing data, targeted surveys, and contact investigations) to improve understanding of tuberculosis transmission dynamics. Development of a locally targeted response for tuberculosis will require substantial investment to reconfigure existing systems, coupled with additional empirical data to evaluate the effectiveness of specific

Lancet2015 Full Text: Link to full Text with Trip Pro

166. Stopping tuberculosis: a biosocial model for sustainable development.

Stopping tuberculosis: a biosocial model for sustainable development. Tuberculosis transmission and progression are largely driven by social factors such as poor living conditions and poor nutrition. Increased standards of living and social approaches helped to decrease the burden of tuberculosis before the introduction of chemotherapy in the 1940s. Since then, management of tuberculosis has been largely biomedical. More funding for tuberculosis since 2000, coinciding with the Millennium (...) Development Goals, has yielded progress in tuberculosis mortality but smaller reductions in incidence, which continues to pose a risk to sustainable development, especially in poor and susceptible populations. These at-risk populations need accelerated progress to end tuberculosis as resolved by the World Health Assembly in 2015. Effectively addressing the worldwide tuberculosis burden will need not only enhancement of biomedical approaches but also rebuilding of the social approaches of the past

Lancet2015

167. Latent Mycobacterium tuberculosis Infection.

Latent Mycobacterium tuberculosis Infection. Latent Mycobacterium tuberculosis Infection. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26376149 Format MeSH and Other Data E-mail Subject Additional text E (...) -mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Sep 17;373(12):1179-80. doi: 10.1056/NEJMc1508223. Latent Mycobacterium tuberculosis Infection. , , . Comment on [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] [N Engl J Med. 2015] PMID: 26376149 DOI: [Indexed for MEDLINE] Free full text Publication types MeSH terms Substances Grant support Full Text

NEJM2015

168. Latent Mycobacterium tuberculosis Infection.

Latent Mycobacterium tuberculosis Infection. Latent Mycobacterium tuberculosis Infection. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26376150 Format MeSH and Other Data E-mail Subject Additional text E (...) -mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Sep 17;373(12):1178. doi: 10.1056/NEJMc1508223#SA1. Latent Mycobacterium tuberculosis Infection. , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26376150 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments How to cite this comment

NEJM2015 Full Text: Link to full Text with Trip Pro

169. Latent Mycobacterium tuberculosis Infection.

Latent Mycobacterium tuberculosis Infection. Latent Mycobacterium tuberculosis Infection. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26376151 Format MeSH and Other Data E-mail Subject Additional text E (...) -mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Sep 17;373(12):1178. doi: 10.1056/NEJMc1508223#SA2. Latent Mycobacterium tuberculosis Infection. , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26376151 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments How to cite this comment

NEJM2015 Full Text: Link to full Text with Trip Pro

170. Latent Mycobacterium tuberculosis Infection.

Latent Mycobacterium tuberculosis Infection. Latent Mycobacterium tuberculosis Infection. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26376152 Format MeSH and Other Data E-mail Subject Additional text E (...) -mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Sep 17;373(12):1178-9. doi: 10.1056/NEJMc1508223#SA3. Latent Mycobacterium tuberculosis Infection. . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26376152 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments How to cite this comment

NEJM2015 Full Text: Link to full Text with Trip Pro

171. Latent Mycobacterium tuberculosis Infection.

Latent Mycobacterium tuberculosis Infection. Latent Mycobacterium tuberculosis Infection. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item: 26376153 Format MeSH and Other Data E-mail Subject Additional text E (...) -mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2015 Sep 17;373(12):1179. doi: 10.1056/NEJMc1508223#SA4. Latent Mycobacterium tuberculosis Infection. , , . Comment in [N Engl J Med. 2015] Comment on [N Engl J Med. 2015] PMID: 26376153 DOI: [Indexed for MEDLINE] Publication types MeSH terms Substances Full Text Sources Medical Miscellaneous PubMed Commons 0 comments How to cite this comment

NEJM2015 Full Text: Link to full Text with Trip Pro

172. Diagnostic Challenges in Latent Tuberculosis Infection: A Brief Review of Available Tests and their Appropriate Use

Diagnostic Challenges in Latent Tuberculosis Infection: A Brief Review of Available Tests and their Appropriate Use Diagnostic Challenges in Latent Tuberculosis Infection: A Brief Review of Available Tests and their Appropriate Use | Clinical Correlations Diagnostic Challenges in Latent Tuberculosis Infection: A Brief Review of Available Tests and their Appropriate Use July 15, 2015 By: Miguel A. Saldivar, MD Peer Reviewed “Indeterminate.” Many clinicians have expressed frustration when reading (...) this word on a Quantiferon-TB Gold test result. The obligate follow-up question is: what is the next best step? Repeat the Quantiferon? Ignore it altogether and perform a Tuberculin Skin Test (TST) instead? Even worse, what happens when both tests are performed with discordant results? In order to answer some of these questions, this article begins with a very brief overview of Mycobacterium tuberculosis (TB) infection epidemiology. This is followed by a review of the tools currently available

Clinical Correlations2015

173. Bedaquiline (Sirturo) - pulmonary multidrug resistant tuberculosis

Bedaquiline (Sirturo) - pulmonary multidrug resistant tuberculosis Final Appraisal Recommendation Advice No: 0815 – March 2015 Bedaquiline (Sirturo ® ? ) 100 mg tablets Submission by Janssen-Cilag Ltd Additional note(s): ? AWMSG considered that bedaquiline (Sirturo ® ? ) satisfies the AWMSG criteria for ultra-orphan drug status. In reaching the above recommendation AWMSG has taken account of the appraisal documentation prepared by the AWMSG Secretariat (reference number 1334), which includes (...) Recommendation of AWMSG Bedaquiline (Sirturo ® ? ) is recommended as an option for use within NHS Wales for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability. Statement of use: No part of this recommendation may be reproduced without the whole recommendation being quoted in full and cited as: All Wales Medicines Strategy Group. Final

All Wales Medicines Strategy Group2015

174. Guidelines on the management of latent tuberculosis infection

Guidelines on the management of latent tuberculosis infection Guidelines on the management of latent tuberculosis infection© World Health Organization 2015 All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: bookorders@who.int). Requests for permission to reproduce (...) Data Guidelines on the management of latent tuberculosis infection. 1.Latent Tuberculosis. 2.Immunologic T ests. 3.Mycobacterium Tuberculosis – immunology. 4.Antitubercular Agents. 5.Guideline. I.World Health Organization. ISBN 978 92 4 154890 8 (NLM classification: WF 200)Guidelines on the management of latent tuberculosis infection1 Guidelines on the management of latent tuberculosis infection Contents Acknowledgements 2 Abbreviations 5 Declaration and management of conflict of interest 6

World Health Organisation Guidelines2015

175. Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis

Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website (...) search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} The study found that rapid molecular tests for rifampicin and isoniazid resistance resistance in tuberculosis were sensitive and specific, and may be cost-effective when added to culture drug susceptibility testing in the UK. {{author}} {{($index , , , , , , , , , , , , & . Francis Drobniewski, 1 ,2 ,3 ,4 ,* Mary Cooke, 5 Jake Jordan, 6 Nicola Casali, 3 ,4

NIHR HTA programme2015

176. Global Tuberculosis Control: Toward the 2015 Targets and Beyond.

Global Tuberculosis Control: Toward the 2015 Targets and Beyond. Since 1990, progress has been made toward global tuberculosis (TB) control, as measured by targets set for 2015. However, TB remains a major threat to health around the world. In 2013, there were an estimated 11 million prevalent cases, and an estimated 9.0 million incident cases occurred globally. Approximately 1.5 million deaths were caused by TB, including 360,000 among people living with HIV. Substantial challenges threaten

Annals of Internal Medicine2015 Full Text: Link to full Text with Trip Pro

177. Effect of a culture-based screening algorithm on tuberculosis incidence in immigrants and refugees bound for the United States: a population-based cross-sectional study.

Effect of a culture-based screening algorithm on tuberculosis incidence in immigrants and refugees bound for the United States: a population-based cross-sectional study. BACKGROUND: Before 2007, immigrants and refugees bound for the United States were screened for tuberculosis (TB) by a smear-based algorithm that could not diagnose smear-negative/culture-positive TB. In 2007, the Centers for Disease Control and Prevention implemented a culture-based algorithm. OBJECTIVE: To evaluate the effect

Annals of Internal Medicine2015 Full Text: Link to full Text with Trip Pro

178. Drug-resistance mechanisms and tuberculosis drugs

Drug-resistance mechanisms and tuberculosis drugs 25706840 2015 02 24 2015 03 03 2016 11 22 1474-547X 385 9965 2015 Jan 24 Lancet (London, England) Lancet Drug-resistance mechanisms and tuberculosis drugs. 305-7 10.1016/S0140-6736(14)62450-8 S0140-6736(14)62450-8 Köser Claudio U CU Department of Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge CB2 0QW, UK. Electronic address: cuk21@cam.ac.uk. Javid Babak B Department of Medicine, Addenbrooke's Hospital, University (...) , Germany. Brown Nicholas M NM Clinical Microbiology and Public Health Laboratory, Public Health England, Cambridge, UK. Burman William J WJ Denver Public Health, Denver, USA. Abubakar Ibrahim I Tuberculosis Section, Centre for Infectious Disease Surveillance and Control, Public Health England, London, UK; Research Department of Infection and Population Health, University College London, London, UK. Ismail Nazir A NA Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg

Lancet2015 Full Text: Link to full Text with Trip Pro

180. [Interferon-gamma release assays as in vitro screening tests for latent tuberculosis infection]

[Interferon-gamma release assays as in vitro screening tests for latent tuberculosis infection] Tests in vitro de dépistage de l'infection tuberculeuse latente par détection de production d'interféron gamma [Interferon-gamma release assays as in vitro screening tests for latent tuberculosis infection] Tests in vitro de dépistage de l'infection tuberculeuse latente par détection de production d'interféron gamma [Interferon-gamma release assays as in vitro screening tests for latent tuberculosis (...) infection] Haute Autorité de Santé Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Haute Autorité de Santé. Tests in vitro de dépistage de l'infection tuberculeuse latente par détection de production d'interféron gamma. [Interferon-gamma release assays as in vitro screening tests for latent tuberculosis infection] Paris: Haute Autorité de Santé

Health Technology Assessment (HTA) Database.2015